In support of this idea, in a recent study using a breast cancer metastasis model, MMTV-PyMT, it was shown that combined use of monophosphoryl lipid A (MPLA) and IFNγ reduced primary tumor growth and metastasis by activating a collaborative innate-adaptive immune response [175]. The gene discussed is IFNG; the disease is breast carcinoma.